| Curtis Mcvay Graf Jr, MD | |
|
3701 Dauphin St, Mobile, AL 36608-1756 | |
| (251) 341-3368 | |
| (251) 341-3404 |
| Full Name | Curtis Mcvay Graf Jr |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 27 Years |
| Location | 3701 Dauphin St, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316941016 | NPI | - | NPPES |
| 0810444 | Other | AL | UNITED HEALTHCARE PROV # |
| 51000273 | Other | AL | BLUE CROSS AL PROVIDER # |
| 7975330 | Other | AL | AETNA PROVIDER NUMBER |
| H41549 | Other | AL | HEALTHSPRING PROVIDER # |
| 51507334 | Other | AL | BLUE CROSS PROVIDER # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 21901 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Springhill Medical Center | Mobile, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Health Management Inc | 6608869342 | 46 |
News Archive
The socioeconomic status of a country has long been considered a potentially significant factor in the availability of high-quality health-care interventions and even a determinant of long-term patient outcomes. A new study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation reports that in Europe, socioeconomic factors have a direct correlation to the rates and outcomes of stem cell transplantation for patients with acute myeloid leukemia (AML).
DePuy Synthes CMF today announced the launch of SYNTHECEL Dura Repair, the first commercially available biosynthesized dural replacement derived from cellulose for use in neurosurgery. DePuy Synthes CMF is a part of the DePuy Synthes Companies of Johnson & Johnson.
Patients with a serious type of inflammatory bowel disease, ulcerative colitis, are not satisfied with their current treatments and the majority do not have their disease under control, according to new research released today at the 9th Congress of the European Crohn's and Colitis Organisation (ECCO) in Copenhagen. The majority (87.2 per cent) of the 250 patients with moderate to severe ulcerative colitis who were being treated with standard therapies failed to achieve control of their disease – defined either as going into remission or not having needed to use corticosteroid medications in the previous two months.1
How many people will die from tobacco use in developed countries in 2030?
› Verified 8 days ago
| Entity Name | Premier Health Management Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538154760 PECOS PAC ID: 6608869342 Enrollment ID: O20040407000654 |
News Archive
The socioeconomic status of a country has long been considered a potentially significant factor in the availability of high-quality health-care interventions and even a determinant of long-term patient outcomes. A new study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation reports that in Europe, socioeconomic factors have a direct correlation to the rates and outcomes of stem cell transplantation for patients with acute myeloid leukemia (AML).
DePuy Synthes CMF today announced the launch of SYNTHECEL Dura Repair, the first commercially available biosynthesized dural replacement derived from cellulose for use in neurosurgery. DePuy Synthes CMF is a part of the DePuy Synthes Companies of Johnson & Johnson.
Patients with a serious type of inflammatory bowel disease, ulcerative colitis, are not satisfied with their current treatments and the majority do not have their disease under control, according to new research released today at the 9th Congress of the European Crohn's and Colitis Organisation (ECCO) in Copenhagen. The majority (87.2 per cent) of the 250 patients with moderate to severe ulcerative colitis who were being treated with standard therapies failed to achieve control of their disease – defined either as going into remission or not having needed to use corticosteroid medications in the previous two months.1
How many people will die from tobacco use in developed countries in 2030?
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Curtis Mcvay Graf Jr, MD 2880 Dauphin St, Mobile, AL 36606-2457 Ph: (251) 341-3368 | Curtis Mcvay Graf Jr, MD 3701 Dauphin St, Mobile, AL 36608-1756 Ph: (251) 341-3368 |
News Archive
The socioeconomic status of a country has long been considered a potentially significant factor in the availability of high-quality health-care interventions and even a determinant of long-term patient outcomes. A new study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation reports that in Europe, socioeconomic factors have a direct correlation to the rates and outcomes of stem cell transplantation for patients with acute myeloid leukemia (AML).
DePuy Synthes CMF today announced the launch of SYNTHECEL Dura Repair, the first commercially available biosynthesized dural replacement derived from cellulose for use in neurosurgery. DePuy Synthes CMF is a part of the DePuy Synthes Companies of Johnson & Johnson.
Patients with a serious type of inflammatory bowel disease, ulcerative colitis, are not satisfied with their current treatments and the majority do not have their disease under control, according to new research released today at the 9th Congress of the European Crohn's and Colitis Organisation (ECCO) in Copenhagen. The majority (87.2 per cent) of the 250 patients with moderate to severe ulcerative colitis who were being treated with standard therapies failed to achieve control of their disease – defined either as going into remission or not having needed to use corticosteroid medications in the previous two months.1
How many people will die from tobacco use in developed countries in 2030?
› Verified 8 days ago
Jeffrey St. John, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 601 Providence Park Dr E, Mobile, AL 36695 Phone: 251-650-2020 Fax: 251-650-1010 | |
Rollins Lynne Tindell Jr., M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2880 Dauphin St, Mobile, AL 36606 Phone: 251-473-1900 Fax: 251-470-8943 | |
Richard Joseph Duffey, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2880 Dauphin St, Mobile, AL 36606 Phone: 251-473-1900 Fax: 251-470-8943 | |
Valerie Lanette Vick, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2880 Dauphin St, Mobile, AL 36606 Phone: 251-473-1900 Fax: 251-470-8943 | |
Mark Scott Brown, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6576 Airport Blvd Ste B200, Mobile, AL 36608 Phone: 251-650-5437 Fax: 800-689-2131 | |
Matthew Wooley Mosteller, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3701 Dauphin St, Mobile, AL 36608 Phone: 251-341-3368 Fax: 251-341-3371 | |
Andrew Pope Terry, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3701 Dauphin St, Mobile, AL 36608 Phone: 251-341-3368 Fax: 251-341-3371 |